Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.9450 (-3.61%) ($4.9450 - $4.9450) on Mon. May. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.33% (three month average) | RSI | 28 | Latest Price | $4.9450(-3.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -12.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(41%) IBB(39%) ARKK(37%) ARKG(36%) XAR(34%) | Factors Impacting ATRA price | ATRA will decline at least -2.665% in a week (0% probabilities). VIXM(-36%) UNG(-24%) VXX(-22%) USO(-18%) XOP(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.665% (StdDev 5.33%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-19.36(-491.51%) | Resistance Level | $5.94 | 5 Day Moving Average | $5.18(-4.54%) | 10 Day Moving Average | $5.25(-5.81%) | 20 Day Moving Average | $5.94(-16.75%) | To recent high | -62.7% | To recent low | 0% | Market Cap | $367m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |